These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3245918)

  • 21. Estrogen receptor mRNA splice variants in pre- and postmenopausal human endometrium and endometrial carcinoma.
    Rice LW; Jazaeri AA; Shupnik MA
    Gynecol Oncol; 1997 Apr; 65(1):149-57. PubMed ID: 9103405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypermethylation of HpaII recognition sequences within the 5' coding region of the estrogen receptor gene is not associated with estrogen receptor negativity in primary breast tumours.
    Kay PH; Hähnel R; Gunn H; Harmon D; Song J
    Anticancer Res; 1998; 18(3A):1709-12. PubMed ID: 9673394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic importance of steroid receptors in endometrial carcinoma.
    Palmer DC; Muir IM; Alexander AI; Cauchi M; Bennett RC; Quinn MA
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):388-93. PubMed ID: 3405554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical importance of determining steroid hormone receptors in endometrial adenocarcinomas].
    Avdeev VI; Kuz'mina ZV; Murav'eva NI; Bassalyk LS; Kozachenko VP
    Vopr Onkol; 1987; 33(6):53-7. PubMed ID: 3617601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cytogenetic aspects of uterine carcinomas].
    De Cecco L; Rugiati S; Sbernini R
    Quad Clin Ostet Ginecol; 1966 Sep; 21(9):562-73. PubMed ID: 5993024
    [No Abstract]   [Full Text] [Related]  

  • 26. Sex steroid receptors in endometrial hyperplasia and neoplasia [proceedings].
    Gurpide E
    Acta Cytol; 1980; 24(6):483-5. PubMed ID: 6934674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant methylation of multiple genes in gastric carcinomas.
    Zhao YF; Zhang YG; Tian XX; Juan Du ; Jie Zheng
    Int J Surg Pathol; 2007 Jul; 15(3):242-51. PubMed ID: 17652530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia.
    Villavicencio A; Bacallao K; Avellaira C; Gabler F; Fuentes A; Vega M
    Gynecol Oncol; 2006 Oct; 103(1):307-14. PubMed ID: 16677694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypermethylation of the myogenic gene Myf-3 in human breast carcinomas.
    Hähnel R; Harvey J; Kay P
    Anticancer Res; 1996; 16(4A):2111-5. PubMed ID: 8712752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Correlation between estrogen receptor(ER), progesterone receptor(PR) and human keratin protein (hKP) in endometrial carcinoma].
    Hatae M; Yagi Y
    Gan No Rinsho; 1983 Dec; 29(15):1740-9. PubMed ID: 6199529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Oestradiol receptors in endometrial carcinomas (author's transl)].
    Görlich M; Heise E; Morack G; Pockrandt H; Seik H; Flach W
    Zentralbl Gynakol; 1982; 104(1):80-5. PubMed ID: 7090633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen and progesterone receptors in uterine sarcomas.
    Sutton GP; Stehman FB; Michael H; Young PC; Ehrlich CE
    Obstet Gynecol; 1986 Nov; 68(5):709-14. PubMed ID: 3763088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Estrogenic receptors in hyperplasia and endometrial adenocarcinoma: immunohystochemical study with image analysis].
    Sánchez Anguiano LF; Puente Ledesma L; Lares Bayona EF; Milla Villeda RH
    Ginecol Obstet Mex; 2007 Sep; 75(9):501-8. PubMed ID: 18293624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors.
    Kato K; Toki T; Shimizu M; Shiozawa T; Fujii S; Nikaido T; Konishi I
    Int J Gynecol Pathol; 2003 Oct; 22(4):334-40. PubMed ID: 14501812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progestin therapy for perimenopausal women.
    Kase NG
    J Reprod Med; 1982 Aug; 27(8 Suppl):522-30. PubMed ID: 7131445
    [No Abstract]   [Full Text] [Related]  

  • 36. Mutational analysis of the estrogen-receptor gene in endometrial carcinoma.
    Kohler MF; Berkholz A; Risinger JI; Elbendary A; Boyd J; Berchuck A
    Obstet Gynecol; 1995 Jul; 86(1):33-7. PubMed ID: 7784019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steroid receptors and endometrial cancer.
    Soper JT; Christensen CW
    Clin Obstet Gynaecol; 1986 Dec; 13(4):825-42. PubMed ID: 3539444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biological essence of the squamous-cell structures in 2-component endometrial cancer].
    Smirnov OA
    Arkh Patol; 1983; 45(6):47-51. PubMed ID: 6625928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gain of OGP, an estrogen-regulated oviduct-specific glycoprotein, is associated with the development of endometrial hyperplasia and endometrial cancer.
    Woo MM; Alkushi A; Verhage HG; Magliocco AM; Leung PC; Gilks CB; Auersperg N
    Clin Cancer Res; 2004 Dec; 10(23):7958-64. PubMed ID: 15585630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Estrogen and progesterone receptor assay in the normal endometrium and endometrial carcinoma].
    Li SY
    Zhonghua Zhong Liu Za Zhi; 1984 Nov; 6(6):429-31. PubMed ID: 6532745
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.